Janin Schulte

Hennigsdorf, BB, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Bio-Adrenomedullin Predicts Death and Major Adverse Cardiovascular Events in Cardiac Amyloidosis: A Cross-Continental Multicenter Study.

Bio-Adrenomedullin Predicts Death and Major Adverse Cardiovascular Events in Cardiac Amyloidosis: A Cross-Continental Multicenter Study.

Journal: Journal of the American Heart Association

Published: December 23, 2025

Peptidylglycine α-amidating monooxygenase and adrenomedullin measurement in patients with hepatic cirrhosis.

Peptidylglycine α-amidating monooxygenase and adrenomedullin measurement in patients with hepatic cirrhosis.

Journal: Biomarkers in medicine

Published: October 09, 2023

Assessing GFR With Proenkephalin.

Assessing GFR With Proenkephalin.

Journal: Kidney international reports

Published: June 14, 2023

Plasma Pro-Enkephalin A and Incident Cognitive Impairment: The Reasons for Geographic and Racial Differences in Stroke Cohort.

Plasma Pro-Enkephalin A and Incident Cognitive Impairment: The Reasons for Geographic and Racial Differences in Stroke Cohort.

Journal: Journal of the American Heart Association

Published: June 01, 2023

Bioactive adrenomedullin (bio-ADM) is associated with endothelial dysfunction in infants and children with complex congenital heart disease undergoing open-heart surgery on cardiopulmonary bypass.

Bioactive adrenomedullin (bio-ADM) is associated with endothelial dysfunction in infants and children with complex congenital heart disease undergoing open-heart surgery on cardiopulmonary bypass.

Journal: Clinical chemistry and laboratory medicine

Published: May 15, 2023

Plasma proenkephalin A and incident chronic kidney disease and albuminuria in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.

Plasma proenkephalin A and incident chronic kidney disease and albuminuria in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.

Journal: BMC nephrology

Published: April 11, 2023

Proenkephalin A and bioactive adrenomedullin are useful for risk prognostication in cardiac surgery.

Proenkephalin A and bioactive adrenomedullin are useful for risk prognostication in cardiac surgery.

Journal: Frontiers in cardiovascular medicine

Published: August 12, 2022

Proenkephalin A as a marker for glomerular filtration rate in critically ill children: validation against gold standard iohexol GFR measurements.

Proenkephalin A as a marker for glomerular filtration rate in critically ill children: validation against gold standard iohexol GFR measurements.

Journal: Clinical chemistry and laboratory medicine

Published: June 02, 2022

Bioactive adrenomedullin for assessment of venous congestion in heart failure.

Bioactive adrenomedullin for assessment of venous congestion in heart failure.

Journal: ESC heart failure

Published: November 30, 2021

Bioactive adrenomedullin in sepsis patients in the emergency department is associated with mortality, organ failure and admission to intensive care.

Bioactive adrenomedullin in sepsis patients in the emergency department is associated with mortality, organ failure and admission to intensive care.

Journal: PloS one

Published: November 24, 2021

Plasma Pro-Enkephalin A and Ischemic Stroke Risk: The Reasons for Geographic and Racial Differences in Stroke Cohort.

Plasma Pro-Enkephalin A and Ischemic Stroke Risk: The Reasons for Geographic and Racial Differences in Stroke Cohort.

Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Published: August 17, 2021

Elevated Plasma Bioactive Adrenomedullin and Mortality in Cardiogenic Shock: Results from the OptimaCC Trial.

Elevated Plasma Bioactive Adrenomedullin and Mortality in Cardiogenic Shock: Results from the OptimaCC Trial.

Journal: Journal of clinical medicine

Published: August 12, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026